FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q2 EPS of $0.09, $0.01 better than the analyst estimate of $0.08. Revenue for the quarter came in at $29.6 million versus the consensus estimate of $29.48 million.
Despite operating under COVID-19 conditions, I am quite pleased with the resiliency of our team... More

